Posted by SAFClive June 18 2013
Join SAFC for the 23rd annual ESACT Meeting taking place in Lille, France from June 23rd through June 26th at Booth # A3.
ESACT was founded 35 years ago and since then has developed into an international reference event in animal cell technology, building on a tradition of combining both basic science and its application into industrial biotechnology.
SAFC is excited to be the silver sponsor this year. We have an action packed schedule that our team has worked on to offer colleagues with a look into SAFC as part of their ESACT experience. We will kick things off on Sunday, June 23rd from 11:15 – 13:15 p.m. at the Artois Room with a presentation on:
Read the rest of this entry »
No Comments | [a]
Filed in: APIs, Bioprocessing, CMO, Fine Chemicals, HPAPIs, Industry Overview, Quality & Regulatory, Supply Chain, Viral Vaccines, ZFN
Posted by SAFClive June 12 2013
Dr. Andreas Weiler
SAFC Lives presents personnel profiles where we talk to the people who make SAFC tick to find out more about their personalities, position, what drives them, and what they enjoy doing when they are not playing a critical role in the ongoing growth of SAFC.
In this edition, we talk with Dr. Andreas Weiler, Strategic Marketing Manager of Pharma Contract Manufacturing Services in Buchs, Switzerland.
Read the rest of this entry »
No Comments | [a]
Filed in: Facilities, Industry Overview, Quality & Regulatory, Supply Chain, Uncategorized
Posted by SAFClive June 7 2013
Gilles Cottier, President of SAFC, was featured in an interview with Hilary Ayshford from Manufacturing Chemist where he shared his journey in the company and his vision as a President.
Gilles spoke to SAFC’s customer intimate approach and how SAFC works to make drugs available and affordable for the global market, enabling a quality life for our future, and picking areas in this vast market where SAFC can play to win.
Read the rest of this entry »
No Comments | [a]
Filed in: Industry Overview, Quality & Regulatory, Supply Chain
Posted by SAFClive June 4 2013
SAFC is pleased to announce that two leading Asian biopharmaceutical companies have signed commercial sales and licensing contracts for the purchase of their off-the-shelf cell line production platform CHOZN®. The customers have confirmed that they will use the platform as a key component in support from development stage through commercialization.
This acts a step towards gaining greater traction in the Asia Pacific market, which SAFC sees as an important market to align with. The purchases also support SAFC’s drive to further integrate the CHOZN platform in the biopharmaceutical space and help customers to drive innovation.
Please see the full press release below. Read the rest of this entry »
No Comments | [a]
Filed in: Bioprocessing, CMO, Industry Overview, Quality & Regulatory, Supply Chain, ZFN
Posted by SAFClive May 31 2013
SAFC would like to invite you to join us for a complimentary 60-minute webcast hosted with Pharmaceutical Technology on Tuesday, June 18th at 11:00 AM EDT. Esteemed industry colleagues from AbbVie and Axendia will join Tom Beil, VP of Quality and Regulatory Affairs at Sigma-Aldrich, to discuss increasing regulatory demands on drug product suppliers and how to formulate a strategic approach for meeting these demands.
Read the rest of this entry »
No Comments | [a]
Filed in: Industry Overview, Quality & Regulatory, Supply Chain
Posted by SAFClive May 29 2013
Biopharmaceutical companies are often challenged by the need to create robust, efficient cell lines with the ability to modify, delete, or add heritable genes. Zinc Finger Nuclease (ZFN) technology has proven to offer an answer to this dilemma.
Read the rest of this entry »
No Comments | [a]
Filed in: Bioprocessing, Fine Chemicals, Industry Overview, Quality & Regulatory, Supply Chain, ZFN
Posted by SAFClive May 23 2013
The 15th annual TIDES conference returned to Boston this May 12th to 15th to bring industry colleagues together with a focus on the discovery and manufacturing of oligonucleotide and peptide therapeutics. SAFC enjoyed being onsite at the four-day event, where it was clear that the importance of oligonucleotides is growing in the pharmaceutical industry. There are now more than 100 oligonucleotide drugs in the clinic, and very many more are in the earlier stages of development.
Read the rest of this entry »
No Comments | [a]
Filed in: Bioprocessing, CMO, Continuous Processing, Facilities, Fine Chemicals, Industry Overview, Quality & Regulatory, Supply Chain
